Get In Fast Walk in or callnext-day appointments available
How does an injection differ from just taking a tablet
When Not to Use Eflornithine Known hypersensitivity to eflornithine or cream excipients Broken, inflamed, or infected skin in the application area Children ( 6 months: Continue maintenance if satisfied
Potential benefits and considerations of DSIP therapy Potential benefits (based on available research) May support natural sleep architecture without pharmacological sedation Non-habit forming does not appear to carry dependency or tolerance risks comparable to benzodiazepines or opiates No reported morning grogginess in available studies Possible complementary effects on stress, pain, and immune regulation May support wellness goals related to longevity, cellular health, and metabolic support Considerations and limitations DSIP is investigational large-scale human clinical trials are limited Injectable forms require proper handling, reconstitution, and refrigeration Effects vary between individuals not all users report the same outcomes Cost may be higher than over-the-counter sleep aids Access requires a consultation with a qualified provider Safety profile and side effects The available research on DSIP suggests a generally favorable safety profile when used under professional supervision
Peptide Vials (NAD+, 500 mg each) 8 weeks: Approximately 11 vials (total ~5,075 mg used) 12 weeks: Approximately 16 vials (total ~7,875 mg used) 16 weeks: Approximately 22 vials (total ~10,675 mg used) Insulin Syringes (U-100, 1 mL) Weekly usage: 7 syringes (one per day) 8 weeks: 56 syringes 12 weeks: 84 syringes 16 weeks: 112 syringes Bacteriostatic Water (10 mL bottles) Each vial requires 3.0 mL for proper reconstitution
